FindTrial
Sign In

Nab-paclitaxel plus Gemcitabine

DRUG3 trials

Sponsors

Chinese PLA General Hospital, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Hutchmed

Conditions

Cancer of PancreasLocally Advanced Pancreatic CancerMetastatic Pancreatic Cancer

Phase 2

Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients
NCT03278015
Chinese PLA General HospitalCancer of Pancreas
Start: 2017-10-01End: 2018-09-30Target: 90Updated: 2017-09-11
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
RecruitingNCT06361888
HutchmedMetastatic Pancreatic Cancer
Start: 2024-05-08End: 2028-05-31Target: 502Updated: 2025-12-30

Unknown Phase

Pancreatic Locally Advanced Irresectable Cancer Ablation
NCT03690323
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Locally Advanced Pancreatic Cancer
Start: 2015-04-07End: 2020-05-31Target: 228Updated: 2018-10-01

Related Papers

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial.
2021-04-2916 citations